Business Description
Humana Inc
NAICS : 621610
SIC : 6324
ISIN : BRH1UMBDR009
Share Class Description:
BSP:H1UM34: BRDRCompare
Compare
Traded in other countries / regions
HUM.USA0J6Z.UKH1UM34.BrazilHUM.MexicoHUM.Germany IPO Date
2020-01-27Description
Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.39 | |||||
| Equity-to-Asset | 0.35 | |||||
| Debt-to-Equity | 0.74 | |||||
| Debt-to-EBITDA | 3.62 | |||||
| Interest Coverage | 4.1 | |||||
| Piotroski F-Score | 4/9 | |||||
| Beneish M-Score | -2.51 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.8 | |||||
| 3-Year EBITDA Growth Rate | -2.3 | |||||
| 3-Year EPS without NRI Growth Rate | 1 | |||||
| 3-Year FCF Growth Rate | -12 | |||||
| 3-Year Book Growth Rate | 7.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -16.28 | |||||
| Future 3-5Y Total Revenue Growth Rate | 3.93 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 65.05 | |||||
| 9-Day RSI | 66.57 | |||||
| 14-Day RSI | 63.86 | |||||
| 6-1 Month Momentum % | -17.48 | |||||
| 12-1 Month Momentum % | -41.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.77 | |||||
| Dividend Payout Ratio | 0.16 | |||||
| 3-Year Dividend Growth Rate | 12.3 | |||||
| Forward Dividend Yield % | 0.82 | |||||
| 5-Year Yield-on-Cost % | 1.38 | |||||
| 3-Year Average Share Buyback Ratio | 1.7 | |||||
| Shareholder Yield % | 1.74 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Net Margin % | 1.18 | |||||
| FCF Margin % | -3.28 | |||||
| ROE % | 8.13 | |||||
| ROA % | 2.68 | |||||
| ROIC % | 7.08 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 26.28 | |||||
| Forward PE Ratio | 18.02 | |||||
| PE Ratio without NRI | 18.8 | |||||
| Shiller PE Ratio | 15.1 | |||||
| PEG Ratio | 1.77 | |||||
| PS Ratio | 0.31 | |||||
| PB Ratio | 2.03 | |||||
| Price-to-Tangible-Book | 4.48 | |||||
| EV-to-EBIT | 16.56 | |||||
| EV-to-Forward-EBIT | 14.24 | |||||
| EV-to-EBITDA | 12.12 | |||||
| EV-to-Forward-EBITDA | 11.03 | |||||
| EV-to-Revenue | 0.38 | |||||
| EV-to-Forward-Revenue | 0.37 | |||||
| EV-to-FCF | -10.04 | |||||
| Price-to-Projected-FCF | 0.68 | |||||
| Price-to-DCF (Earnings Based) | 0.73 | |||||
| Price-to-Median-PS-Value | 0.48 | |||||
| Price-to-Graham-Number | 1.94 | |||||
| Earnings Yield (Greenblatt) % | 6.04 | |||||
| FCF Yield % | -12.16 | |||||
| Forward Rate of Return (Yacktman) % | 8.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Humana Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil R$) | 599,015.467 | ||
| EPS (TTM) (R$) | 1.358 | ||
| Beta | -0.56 | ||
| Volatility % | 36.17 | ||
| 14-Day RSI | 63.86 | ||
| 14-Day ATR (R$) | 0.894372 | ||
| 20-Day SMA (R$) | 36.0355 | ||
| 12-1 Month Momentum % | -41.23 | ||
| 52-Week Range (R$) | 26.25 - 56.56 | ||
| Shares Outstanding (Mil) | 5,418.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Humana Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Humana Inc Stock Events
| Event | Date | Price(R$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Humana Inc Frequently Asked Questions
What is Humana Inc(BSP:H1UM34)'s stock price today?
The current price of BSP:H1UM34 is R$38.68. The 52 week high of BSP:H1UM34 is R$56.56 and 52 week low is R$26.25.
When is next earnings date of Humana Inc(BSP:H1UM34)?
The next earnings date of Humana Inc(BSP:H1UM34) is 2025-01-24 Est..
Does Humana Inc(BSP:H1UM34) pay dividends? If so, how much?
The Dividend Yield %  of Humana Inc(BSP:H1UM34) is 0.77% (As of Today), Highest Dividend Payout Ratio of Humana Inc(BSP:H1UM34) was 0.19. The lowest was 0.1. And the median was 0.14. The  Forward Dividend Yield % of Humana Inc(BSP:H1UM34) is 0.82%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers